Merck defeats earnings desires, brings up purchases outlook on solid need for top medications like Keytruda - CNBC

.Merck trumps earnings requirements, brings up sales overview on tough demand for top drugs like Keytruda CNBCMerck &amp Co. (MRK United States) Defeats Income Forecasts as Keytruda Purchases Growth BloombergMerck Stock: Pharma Giant Posts Solid End Results, Yet Overview Falls Short Client's Organization DailyMerck Announces Second-Quarter 2024 Financial Results Yahoo FinanceMerck defeats earnings and sales desires amidst Keytruda advantage, yet gives mixed full-year overview MarketWatch.